Bloated reserves undermine growth potential

Published: 2012-04-27 06:56:00

Updated: 2012-04-27 06:56:00

Pharmaceutical companies are piling up internal reserves instead of investing for the future, undermining their growth potential. Companies opted to hold back their capital spending due to the uncertain business outlook and what they call inconsistent government policies.

The cash reserve rati...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK